CryoLife, Inc. Appoints David Ashley Lee Chief Financial Officer

ATLANTA, April 19 /PRNewswire/ -- Steven G. Anderson, President and Chief Executive Officer, CryoLife, Inc. (NYSE: CRY), today announced the appointment of David Ashley Lee, 35, as Vice President of Finance and Chief Financial Officer of CryoLife, Inc. Mr. Lee has served as CryoLife's Controller since 1994.

Prior to joining CryoLife, Inc., Mr. Lee was Director of Finance at Compass Retail, a wholly-owned subsidiary of Equitable Real Estate. Mr. Lee was also an audit manager with Ernst & Young for seven years, 1987-1993. He holds a BS degree in Accounting from the University of Mississippi and is a Certified Public Accountant.

Mr. Anderson noted that, "Over the past six years, Mr. Lee has displayed outstanding abilities in corporate finance and is well positioned for his new responsibilities. His appointment is also in keeping with Company policy to promote capable individuals from within."

Mr. Lee succeeds Edwin B. Cordell, Jr., who resigned the position of Vice President and Chief Financial Officer to pursue other career opportunities.

Anderson went on to say, "We would like to thank Ed for his many contributions during the last six years. He has been very successful in building a strong accounting department that is positioned to assume the projects that he has started."

Ed Cordell said, "Helping to build CryoLife over the past six years was rewarding and fruitful. I am very pleased that CryoLife has decided to promote someone whom I have worked closely with in building a strong financial organization."

Founded in 1984, CryoLife, Inc. is the leader in the development and commercialization of implantable living human tissues for use in cardiovascular, vascular, and orthopaedic surgeries throughout the United States and Canada. The Company's BioGlue(R) surgical adhesive, CE marked in the European Union for use in vascular and pulmonary sealing and repair, is distributed throughout Europe. The Company also manufactures CryoLife-O'Brien(R) and CryoLife-Ross(R) stentless porcine heart valves which are distributed within the European Community.

For additional information about the Company, visit CryoLife's web site -- http://www.cryolife.com

SOURCE CryoLife, Inc.

CONTACT: Roy Vogeltanz, Vice President, Corporate Communications of CryoLife, 800-438-8285/